Analgesics
Antiandrogens
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lactoferrin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Quercetin
Remdesivir
Vitamins

Other
Feedback
Home
Top
Results
Abstract
All vitamin C studies
Meta analysis
 
Feedback
Home
c19early.org COVID-19 treatment researchVitamin CVitamin C (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ IgG positive -26% Improvement Relative Risk Vitamin C for COVID-19  Mahto et al.  Prophylaxis Is prophylaxis with vitamin C beneficial for COVID-19? Retrospective 689 patients in India Higher IgG positivity with vitamin C (not stat. sig., p=0.49) c19early.org Mahto et al., American J. Blood Research, Feb 2021 Favors vitamin C Favors control

Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India

Mahto et al., American Journal of Blood Research, 11:1
Feb 2021  
  Twitter
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Retrospective 689 healthcare workers in India, showing no significant difference in IgG positivity with vitamin C prophylaxis.
This is the 13th of 63 COVID-19 controlled studies for vitamin C, which collectively show efficacy with p=0.00000026. 16 studies are RCTs, which show efficacy with p=0.00000018.
This study includes diet, HCQ, vitamin C, and zinc.
risk of IgG positive, 25.9% higher, RR 1.26, p = 0.49, treatment 34 of 140 (24.3%), control 59 of 549 (10.7%), adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Mahto et al., 15 Feb 2021, retrospective, India, peer-reviewed, 6 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin CAll
Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India
Mala Mahto, Ayan Banerjee, Bijit Biswas, Sushil Kumar, Neeraj Agarwal, Prabhat Kumar Singh
Healthcare workers (HCWs) due to their job profile are at utmost risk of contracting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Serological survey is an useful tool for vulnerability mapping in an infectious disease pandemic. The aim of the current study was to assess seroprevalence of IgG against SARS-CoV-2 and its determinants among HCWs of a tertiary healthcare facility of India. It was an observational study, cross-sectional in design conducted among
Am J Blood Res 2021;11(1):44-52 have played a role as nurses and doctors by virtue of their professional training likely to be more aware of infection prevention and control (IPC) measures to be taken for contagious disease like COVID-19. Thus, they might have taken more precaution in comparison to the other staffs to get themselves protected from SARS-CoV-2 infection. Similarly, we found place of posting as significant attribute affecting IgG seropositivity among the study subjects as in * data for all the variables were available for 689 study subjects thus it was used for performing logistic regression analysis; ICU: intensive care unit, PPE: personal protective equipment, ILI: influenza like illness, HCQ: hydroxychloroquine, COR: crude odds ratio, AOR: adjusted odds ratio, CI: confidence interval. Am J Blood Res 2021;11(1):44-52 involved in the study. Without their unconditional support the study would not have been possible. We received no additional fund for the study. The institutional fund as part of healthcare workers health policy was utilised for this study. Disclosure of conflict of interest None. Address correspondence to: Dr. Bijit Biswas, Department of Community and Family Medicine, All India Institute of Medical Sciences, Phulwarisharif, Patna 801507, Bihar, India. Tel: +917003881125; E-mail: drbijitbiswas@gmail.com
References
Amendola, Tanzi, Folgori, Barcellini, Bianchi et al., Low seroprevalence of SARS-CoV-2 infection among healthcare workers of the largest children hospital in Milan during the pandemic wave, Infect Control Hosp Epidemiol
Andrews, Rajesh, Krishnan, Suryakala, Krishnan et al., First confirmed case of COVID-19 infection in India: a case report, Indian J Med Res
Baveja, Karnik, Natraj, Natkar, Bakshi et al., Rapid volunteer-based SARS-Cov-2 antibody screening among health care workers of a hospital in Mumbai, India, Indian J Med Sci
Bleyzac, Goutelle, Bourguignon, Tod, Azithromycin for COVID-19: more than just an antimicrobial?, Clin Drug Investig
Craddock, Neale, Peoples, Probst, Vegetarian-based dietary patterns and their relation with inflammatory and immune biomarkers: a systematic review and metaanalysis, Adv Nutr
Didzun, Neve, Awasthi, Dubey, Theilmann et al., Anaemia among men in India: a nationally representative cross-sectional study, Lancet Glob Health
Dowell, Turner, Closing evidence to practice gaps: an end to an attack of the vapours?, Br J Gen Pract
Garcia-Basteiro, Moncunill, Tortajada, Vidal, Guinovart et al., Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital, Nat Commun
Gates, Responding to Covid-19 -a once-in-acentury pandemic?, N Engl J Med
Jonker, Van Hensbroek, Anaemia, iron deficiency and susceptibility to infections, J Infect
Khalil, Barma, Sub-continental atmosphere and inherent immune system may have impact on novel corona virus' 2019 (nCovid-19) prevalence in South East Asia, Mymensingh Med J
Kumar, Bhartiya, Desai, Mutha, Beldar et al., Seroprevalence of antibodies against SARS-CoV-2 among health care work, Am J Blood Res
Martin, Montesinos, Dauby, Gilles, Dahma et al., Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff, J Hosp Infect
Martin, Montesinos, Dauby, Gilles, Dahma et al., Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff, J Hosp Infect
Metcalf, Farrar, Cutts, Basta, Graham et al., Use of serological surveys to generate key insights into the changing global landscape of infectious disease, Lancet Lond Engl
Mughal, Kaur, Patton, Mikhail, Vareechon et al., The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications-a single-center, prospective, pilot study, Infect Control Hosp Epidemiol
Ng, Poon, Puar, Quah, Loh et al., CO-VID-19 and the risk to health care workers: a case report, Ann Intern Med
Nguyen, Drew, Graham, Joshi, Guo et al., Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study, Lancet Public Health
Patel, Thornburg, Stubblefield, Talbot, Coughlin et al., Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in nashville, tennessee, JAMA
Prakash, Solanki, Sheth, Joshi, Kadam et al., Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study, BMJ Open
Schmidt, Grüter, Boltzmann, Rollnik, Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff, PLoS One
Sotgiu, Barassi, Miozzo, Saderi, Piana et al., SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital, BMC Pulm Med
Wessels, Rolles, Rink, The potential impact of zinc supplementation on COVID-19 pathogenesis, Front Immunol
Yamamoto, Bauer, Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: four hypotheses for possible explanation, Med Hypotheses
Zhao, Wang, Wang, Zhao, Zheng et al., Asymptomatic infection by SARS-CoV-2 in healthcare workers: a study in a large teaching hospital in Wuhan, China, Int J Infect Dis
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit